ADAKVEO® (crizanlizumab-tmca)

What makes ADAKVEO different?

What is ADAKVEO?

ADAKVEO is a prescription medication that is:

  • The first and only FDA-approved, once-monthly medication to reduce the number of pain crises in sickle cell disease
  • A biologic, which is a protein-based medication that is made from living sources. ADAKVEO is an IV infusion given by a health care provider
  • A kind of therapy called a targeted biologic, which means it works within your body by attaching to P-selectin—a key sticky factor in the blood

How does ADAKVEO work?

ADAKVEO works by making blood vessels and certain blood cells less sticky.


How ADAKVEO works

Talking to your doctor about ADAKVEO

Watch this video to help you understand treatment with ADAKVEO.


Talk to your doctor today about how ADAKVEO may play an essential role in your plan to manage episodes (crises) in sickle cell disease.